Increased expression of ECT2 predicts the poor prognosis of breast cancer patients.

Authors:
Yi M; Zhang D; Song B; Zhao B; Niu M and 3 more

Journal:
Exp Hematol Oncol

Publication Year: 2022

DOI:
10.1186/s40164-022-00361-3

PMCID:
PMC9791744

PMID:
36572949

Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"availability of data and materials the tcga datasets for this study can be found in the https://xenabrowser net/datapages/ . the gse25066"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the ethics committee of the Tongji Hospital of Huazhong University of Science and Technology. Consent for publicationNot applicable. Competing interestsThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. As the editorial board member of Experimental Hematology & Oncology, KW decleare that he has no competing interests and is excluded from the peer review process. This submission is not given any priority over other manuscripts, and editorial board member status has no bearing on editorial consideration. Competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. As the editorial board member of Experimental Hematology & Oncology, KW decleare that he has no competing interests and is excluded from the peer review process. This submission is not given any priority over other manuscripts, and editorial board member status has no bearing on editorial consideration."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (Nos. 81874120 and 82272794)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025